Target Protein-binding moiety 4 (Synonyms: Molibresib carboxylic acid; GSK525762A carboxylic acid; PROTAC BRD4-binding moiety 2) |
| Catalog No.GC32863 |
Target Protein-binding moiety 4(Molibresib carboxylic acid)는 BET에 대한 PROTAC 표적의 접합 반응을 위한 I-BET762 기반 탄두 리간드입니다. Target Protein-binding moiety 4(Molibresib carboxylic acid)는 pIC50이 5.1인 BRD4 억제제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1300019-38-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Target Protein-binding moiety 4 is a BRD4(1) inhibitor with an IC50 of 7.9 μM.
Target Protein-binding moiety 4 (compound 32) is a BRD4 (1) inhibitor with an IC50 of 7.9 μM[1].
[1]. Yifei Yang, et al. Combined pharmacophore models as virtual screening protocol against BRD4(1) inhibitor. Medicinal Chemistry Research (2016), 25(4), 585-595.
Average Rating: 5 (Based on Reviews and 40 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *